Bio-Rad Laboratories (BIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Sales | 533,720 | 471,502 | 467,662 | 454,234 | 495,073 |
| Cost of Goods | 233,997 | 205,172 | 199,354 | 197,107 | 226,604 |
| Gross Profit | 299,723 | 266,330 | 268,308 | 257,127 | 268,469 |
| Operating Expenses | 222,936 | 191,700 | 200,486 | 193,987 | 212,778 |
| Operating Income | 77,784 | 74,802 | 68,176 | 63,247 | 56,295 |
| Interest Expense | 20,548 | 14,400 | 14,325 | 14,444 | 14,363 |
| Other Income | -35 | -2,493 | 1,503 | 1,016 | 161 |
| Pre-tax Income | 57,201 | 57,909 | 55,354 | 49,819 | 42,093 |
| Income Tax | -10,736 | 12,824 | 16,833 | 14,427 | 3,571 |
| Net Income Continuous | 67,937 | 45,085 | 38,521 | 35,392 | 38,522 |
| Minority Interests | 29 | 321 | 564 | 531 | 660 |
| Net Income | $67,908 | $44,764 | $37,957 | $34,861 | $37,862 |
| EPS Basic Total Ops | 2.44 | 1.62 | 1.37 | 1.27 | 1.38 |
| EPS Basic Continuous Ops | 2.45 | 1.63 | 1.40 | 1.28 | 1.40 |
| EPS Diluted Total Ops | 2.41 | 1.59 | 1.35 | 1.24 | 1.35 |
| EPS Diluted Continuous Ops | 2.41 | 1.60 | 1.37 | 1.26 | 1.37 |
| EBITDA(a) | $77,784 | $74,802 | $68,176 | $63,247 | $56,295 |